Mecanismos de señalización celular en enfermedades hepáticas, cardiovasculares y cáncer
Instituto de Investigación Sanitaria del Hospital Universitario La Paz
Madrid, EspañaInstituto de Investigación Sanitaria del Hospital Universitario La Paz-ko ikertzaileekin lankidetzan egindako argitalpenak (4)
2020
-
Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR
Frontiers in Immunology, Vol. 11
-
Targeting β2-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from von Hippel–Lindau disease
Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-30
2018
-
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
Nature Communications, Vol. 9, Núm. 1
-
Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” (Redox Biol. (2017) 13 (94–162)(S2213231717303373)(10.1016/j.redox.2017.05.007))
Redox Biology